Characteristics | No. (%) | |
---|---|---|
Normal mucosa (n = 415,092) | Reference (n = 1,939,215) | |
Age at cohort entry, years a | ||
Mean ± SD | 42.6 ± 19.9 | 41.4 ± 19.6 |
Median (IQR) | 41.6 (26.5, 57.6) | 40.2 (25.8, 55.9) |
< 18 y | 37,162 (9.0) | 185,918 (9.6) |
18–39.9 y | 159,128 (38.3) | 776,081 (40.0) |
40–59.9 y | 128,543 (31.0) | 597,589 (30.8) |
≥ 60 y | 90,259 (21.7) | 379,627 (19.6) |
Sex | ||
Male | 161,935 (39.0) | 774,466 (39.9) |
Female | 253,157 (61.0) | 1,164,749 (60.1) |
Country of birth | ||
Nordic country | 372,414 (89.7) | 1,695,737 (87.4) |
Other country | 42,678 (10.3) | 243,478 (12.6) |
Biopsy location b | ||
Upper GI | 252,130 (60.7) | 1,178,909 (60.8) |
Lower GI | 162,962 (39.3) | 760,306 (39.2) |
Calendar period of cohort entry | ||
1969–1989 | 37,065 (8.9) | 175,750 (9.1) |
1990–1999 | 105,966 (25.5) | 497,625 (25.7) |
2000–2009 | 159,364 (38.4) | 741,892 (38.3) |
2010–2016 | 112,697 (27.2) | 523,948 (27.0) |
Educational attainment | ||
0–9 y | 87,205 (21.0) | 401,459 (20.7) |
10–12 y | 155,033 (37.4) | 705,301 (36.4) |
≥ 13 y | 103,714 (25.0) | 486,016 (25.1) |
Missing | 69,140 (16.7) | 346,439 (17.9) |
Number of healthcare visit | ||
0 | 262,249 (63.2) | 1,474,064 (76.0) |
1 | 63,749 (15.4) | 231,583 (11.9) |
2–3 | 48,551 (11.7) | 144,925 (7.5) |
≥ 4 | 40,543 (9.8) | 88,643 (4.6) |
Charlson comorbidity index | ||
0 | 336,937 (81.2) | 1,732,278 (89.3) |
1 | 58,881 (14.2) | 165,699 (8.5) |
≥ 2 | 19,274 (4.6) | 41,238 (2.1) |
History before start of follow-up | ||
GI disease | 192,744 (46.4) | 269,048 (13.9) |
Endoscopy | 129,815 (31.3) | 40,494 (2.1) |
Colectomy or proctocolectomy | 283 (0.1) | 275 (0.0) |
Follow-up years since biopsy | ||
Median (IQR) | 10.9 (5.7, 17.8) | 11.1 (5.8, 18.2) |
0.5–1 y | 5460 (1.3) | 22,315 (1.2) |
1–4.9 y | 82,598 (19.9) | 378,898 (19.5) |
5–9.9 y | 102,809 (24.8) | 471,651 (24.3) |
10–19.9 y | 147,159 (35.5) | 687,486 (35.5) |
20–29.9 y | 64,044 (15.4) | 313,228 (16.2) |
≥ 30 y | 13,022 (3.1) | 65,637 (3.4) |